DrugPatentWatch Database Preview
Profile for Canada Patent: 2779711
» See Plans and Pricing
US Patent Family Members and Approved Drugs for Canada Patent: 2779711
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Mar 2, 2031 | Allergan | FETZIMA | levomilnacipran hydrochloride |
Start Trial | May 23, 2032 | Allergan | FETZIMA | levomilnacipran hydrochloride |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |